Covalent, a provider of materials characterization, metrology, failure analysis, and related analytical services, today ...

Researchers developed a photocatalytic covalent organic framework that selectively captures gold from electronic waste ...

The newly designed two-dimensional COF features abundant adsorption sites and favorable photoelectronic properties, ...

TOS-358 is a covalent, pan-mutant, a-selective PI3K inhibitor designed to address key limitations of existing PI3Ka therapies which include ...

Local business honored with 2026 statewide award on April 22 Receiving the Michigan 50 Companies to Watch award is a ...

For BTK inhibitor selection in frontline CLL treatment, age, risk profile, and long-term sequencing strategy influence ...

TOS-358 is a covalent, pan-mutant, a-selective PI3K inhibitor designed to address key limitations of existing PI3Ka therapies which include limited mutation coverage and poor tolerability ...

A battery usually hides its nastiest chemistry from view. Inside many rechargeable systems, useful energy moves through ...

RMIT University researchers have developed a new way to coat fragile surfaces, including living plant leaves, using ...

Title: Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Session: Late-Breaking Poster Session 2871-LB Presenter: Mini Balakrishnan, Ph.D. Date/Time: June 7, 2026, at 12:30 ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd., an ...